🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate whether prompt initiation and maintenance of Brezt...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-19
Trial ID
NCT05970263
This is a randomized, double-blind, single-dose, placebo-controlled, 5-peri...
Status
Completed
Location
Research Site
Start Date
2017-12-15
Trial ID
NCT03364608
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter, parall...
Status
Completed
Location
Research Site
Start Date
2019-03-20
Trial ID
NCT03847896
Treatments Being Tested
The purpose of this study is to compare the effect of budesonide/albuterol ...
Status
Recruiting
Location
Research Site
Start Date
2024-05-20
Trial ID
NCT06307665
This study will evaluate the dose response relationship among four doses of...
Status
Completed
Location
Novartis Investigator site
Start Date
2007-10
Trial ID
NCT00557466
Treatments Being Tested
This is a randomized, cumulative dose, open-label, 2-period crossover, mult...
Status
Completed
Location
Research Site
Start Date
2017-12-29
Trial ID
NCT03371459
The purpose of this Phase III, multicentre, randomized, double-blind, singl...
Status
Completed
Location
Research Site
Start Date
2023-12-22
Trial ID
NCT06245551
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of albutero...
Status
Completed
Location
Research Site
Start Date
2024-09-11
Trial ID
NCT06563102
Treatments Being Tested
An event-driven, Phase III study to evaluate the efficacy and safety of BDA...
Status
Recruiting
Location
Research Site
Start Date
2024-06-17
Trial ID
NCT06471257
Treatments Being Tested
A phase I study to assess the PK, safety, and tolerability of budesonide an...
Status
Completed
Location
Research Site
Start Date
2024-08-19
Trial ID
NCT06514157
Treatments Being Tested